April 19, 2024

Accelerating Patient Access to Advanced Cell-based Therapies through the Signature of a Service Agreement between the French CDMO and the Toulouse University Hospital (CHU Toulouse).

Accelerating Patient Access to Advanced Cell-based Therapies through the Signature of a Service Agreement between the French CDMO and the Toulouse University Hospital (CHU Toulouse) Toulouse, France, April 18, 2024 – This agreement between the two parties opens great perspectives for Biotechs, providing them with seamless access to patients who

+ Read More
CAR (chimeric antigen receptor) T-cell illustration.
March 28, 2024

Cell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T Therapy.

Cell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T Therapy Toulouse, France, march 26, 2024 –  This agreement with a pioneer European C&G company will soon enable the initiation of new clinical trials in South of France based on innovative CAR-T cell treatments  

+ Read More
November 21, 2023

Cell-Easy and Toulouse University Hospital obtain IMPD approval for first-in-human clinical trial in systemic sclerosis, using promising allogeneic approach

EU regulatory approval to administer Adipose-derived mesenchymal Stem Cells (ASCs) in patients with ischemic digital ulcers marks key milestone for partners Toulouse, France, November 16, 2023 – Cell-Easy, a French Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies, and the Toulouse University Hospital, today announce that they

+ Read More

your CDMO Partner for Cell-Therapy

Keep in touch
Linkedin

Cell-Easy

4 Bis avenue Hubert Curien

31320 Toulouse, FRANCE

Science-driven CDMO specialized in Cell Therapy, Cell-Easy offers customized process development, GMP manufacturing and analytical services for immune cells and adult stem cells in Immuno-oncology and Regenerative Medicine fields.

Privay Policy